Inhibition of NF-κB DNA Binding by Nitric Oxide

It has been suggested that the NF-kappaB transcription factor family may mediate expression of the gene encoding the cytokine-inducible form of nitric oxide synthase (iNOS). To establish if nitric oxide (NO) could in turn affect activity of NF-kappaB, the ability of NO-donor compounds to influence NF-kappaB DNA binding activity in vitro was investigated. NO-donor compounds sodium nitroprusside (SNP) and S-nitroso-N-acetylpenicillamine (SNAP) both inhibited the DNA binding activity of recombinant NF-kappaB p50 and p65 homodimers and of p50-p65 heterodimers. Inhibition of NF-kappaB p50 DNA binding by NO-donor compounds involved modification of the conserved redox-sensitive C62 residue, as a C62S p50 mutant was significantly more resistant to SNP-mediated inactivation. Non-reducing SDS-polyacrylamide gel electrophoresis demonstrated that SNP could inhibit p50 DNA binding by mechanisms other than the formation of intersubunit disulphide bonds involving p50 residue C62. Electrospray ionization mass spectrometry of a synthetic NF-kappaB p5O peptide containing the C62 residue suggested that NO gas can modify C62 by S-nitrosylation. This study indicates that NO-donors can directly inhibit the DNA binding activity of NF-kappaB family proteins, suggesting that cellular NO provides another control mechanism for modulating the expression of NF-kappaB-responsive genes.

[1]  Carl Nathan,et al.  Nitric oxide synthases: Roles, tolls, and controls , 1994, Cell.

[2]  P. Baeuerle,et al.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.

[3]  I. Verma,et al.  Autoregulation of I kappa B alpha activity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  B. Brüne,et al.  Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. , 1992, The Journal of biological chemistry.

[5]  J. Stamler,et al.  Biochemistry of nitric oxide and its redox-activated forms. , 1992, Science.

[6]  C. Gélinas,et al.  The RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein , 1992, Molecular and cellular biology.

[7]  P. Libby,et al.  Induction and Stabilization of IκBα by Nitric Oxide Mediates Inhibition of NF-κB (*) , 1995, The Journal of Biological Chemistry.

[8]  P. Sehajpal,et al.  Nitric oxide signaling: a possible role for G proteins. , 1993, Journal of immunology.

[9]  F. Bach,et al.  Cytokine‐inducible expression in endothelial cells of an I kappa B alpha‐like gene is regulated by NF kappa B. , 1993, The EMBO journal.

[10]  S. Lipton,et al.  Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV- associated neurological disease , 1995, The Journal of experimental medicine.

[11]  P. Libby,et al.  Nitric Oxide Inhibits Macrophage-Colony Stimulating Factor Gene Transcription in Vascular Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.

[12]  R. Hay,et al.  Sequence requirement for specific interaction of an enhancer binding protein (EBP1) with DNA. , 1989, Nucleic acids research.

[13]  P. Kourilsky,et al.  The characterization of the promoter of the gene encoding the p50 subunit of NF‐kappa B indicates that it participates in its own regulation. , 1992, The EMBO journal.

[14]  D. Levine,et al.  Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. , 1993, Journal of immunology.

[15]  W. Leonard,et al.  Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Hay,et al.  Regulation of the DNA binding activity of NF-κB , 1995 .

[17]  J. Stamler,et al.  Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation , 1994, Cell.

[18]  F. Chen,et al.  Dependence and reversal of nitric oxide production on NF-kappa B in silica and lipopolysaccharide-induced macrophages. , 1995, Biochemical and biophysical research communications.

[19]  W. Leonard,et al.  N-terminal DNA-binding domains contribute to differential DNA-binding specificities of NF-kappa B p50 and p65 , 1993, Molecular and cellular biology.

[20]  M. Moskowitz,et al.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. , 1994, Science.

[21]  Gregory L. Verdine,et al.  Structure of the NF-κB p50 homodimer bound to DNA , 1995, Nature.

[22]  A. Israël,et al.  Promoter analysis of the gene encoding the I kappa B‐alpha/MAD3 inhibitor of NF‐kappa B: positive regulation by members of the rel/NF‐kappa B family. , 1993, The EMBO journal.

[23]  W. Greene,et al.  Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Hay,et al.  Enhancer binding protein (EBP1) makes base and backbone contacts over one complete turn of the DNA double helix. , 1989, Journal of molecular biology.

[25]  B. Chait,et al.  Monitoring Reactions of Nitric Oxide with Peptides and Proteins by Electrospray Ionization-Mass Spectrometry (*) , 1995, The Journal of Biological Chemistry.

[26]  J. Yodoi,et al.  Thiordoxin regulates the DNA binding activity of NF-χB by reduction of a disulphid bond involving cysteine 62 , 1992 .

[27]  U. Walter,et al.  NO at work , 1994, Cell.

[28]  J. Liu,et al.  Evidence for a non-alpha-helical DNA-binding motif in the Rel homology region. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Stamler,et al.  Redox signaling: Nitrosylation and related target interactions of nitric oxide , 1994, Cell.

[30]  M. Tsuda,et al.  Modulation of AP‐1 activity by nitric oxide (NO) in vitro: NO‐mediated modulation of AP‐1 , 1994, FEBS letters.

[31]  T. Okamoto,et al.  Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. , 1993, The Journal of biological chemistry.

[32]  P. Sigler,et al.  Structure of NF-κB p50 homodimer bound to a κB site , 1998, Nature.

[33]  C. Nathan,et al.  Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. , 1994, The Journal of biological chemistry.

[34]  F. Arenzana‐Seisdedos,et al.  HIV enhancer activity perpetuated by NF-κB induction on infection of monocytes , 1991, Nature.

[35]  T. Curran,et al.  Redox regulation of fos and jun DNA-binding activity in vitro. , 1990, Science.

[36]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[37]  C. Caldarera,et al.  Induction of Nitric Oxide Synthase mRNA Expression , 1995, The Journal of Biological Chemistry.

[38]  Timothy N. C. Wells,et al.  Role of cysteine62 in DNA recognition by the P50 subunit of NF-xB , 1993 .

[39]  D. Thomas,et al.  Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B , 1995, Molecular and cellular biology.

[40]  P. Baeuerle,et al.  H2O2 and antioxidants have opposite effects on activation of NF‐kappa B and AP‐1 in intact cells: AP‐1 as secondary antioxidant‐responsive factor. , 1993, The EMBO journal.

[41]  E. Hoffman,et al.  Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. , 1994, The Journal of biological chemistry.